Skip to main content

The full view of the presentation slides are occasionally obstructed throughout this recording, please find a copy of the presentation slides here.

Resources mentioned in the webinar:

https://www.hse.ie/eng/about/who/cspd/ncps/medicines-management/guidance-on-shortages/

https://www.hse.ie/eng/about/who/cspd/ncps/medicines-management/guidance-on-shortages/mmp-guidance-for-prescribers-on-hrt-shortages-september-2020.pdf

Speakers: 

  • Dr. Deirdre Lundy, Registered Menopause Specialist with the British Menopause Society (BMS), Clinical Lead for the National Maternity Hospital's Complex Menopause Clinic 

Summary: 
In this webinar "Pharmaceutical care during Perimenopause and Menopause" Dr. Deirdre Lundy covers a range of topics related to pharmaceutical care during perimenopause and menopause. She discusses symptoms, non-hormonal treatment options, safety considerations, the availability of pharmaceutical care in different areas, the use of hormone replacement therapy (HRT), breast cancer risk, and HRT options for specific patient groups. She emphasises the importance of individualised care and providing patients with accurate information to make informed decisions about their health. Overall, Dr. Deirdre Lundy provides a comprehensive overview of pharmaceutical care during perimenopause and menopause, taking into account various factors and considerations.